Dual A 1 and A 2A adenosine receptor antagonists, methoxy substituted 2-benzylidene-1-indanone, suppresses intestinal postprandial glucose and attenuates hyperglycaemia in fructose-streptozotocin diabetic rats.
Olakunle SanniDavid D N'DaPublished in: BMC endocrine disorders (2023)
ARs presents a positive synergism that could provide a new possibility for the treatment of diabetes.